Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms

Mycoses

Volumn 55, Issue 1, 2012, Pages 80-85

  Martins, Margarida ^a   Henriques, Mariana ^a   Lopez Ribot, José L ^b   Oliveira, Rosário ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Amphotericin B; Antifungal adjuvant; C. albicans biofilm; Caspofungin; Fluconazole

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; DEOXYRIBONUCLEASE I; FLUCONAZOLE; PHENOL DERIVATIVE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; ENZYME ACTIVITY; IN VITRO STUDY; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; DEOXYRIBONUCLEASES; DRUG COMBINATIONS; ECHINOCANDINS; FLUCONAZOLE; MICROBIAL SENSITIVITY TESTS; MITOCHONDRIA; REPRODUCIBILITY OF RESULTS; TETRAZOLIUM SALTS;

CANDIDA ALBICANS;

EID: 83655192068     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2011.02047.x     Document Type: Article

References (27)

1. d'Enfert C. Hidden killers: persistence of opportunistic fungal pathogens in the human host. Curr Opin Microbiol 2009; 12: 358-64.
2. Seneviratne CJ, Jin LJ, Samaranayake YH, Samaranayake LP. Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms. Antimicrob Agents Chemother 2008; 52: 3259-66.
3. Nett J, Lincoln L, Marchillo K. et al. Putative role of beta-1, 3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother 2007; 51: 510-20.
4. Vediyappan G, Rossignol T, d'Enfert C. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans. Antimicrob Agents Chemother 2010; 54: 2096-111.
5. Martins M., Uppuluri P, Thomas DP et al. Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms. Mycopathologia 2010; 169: 323-31.
6. Clinical Laboratory Standard Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved standard, M27-A3. Wayne, PA: Clinical Laboratory Standard Institute, 2008.
7. Tetz VV, Tetz GV. Effect of extracellular DNA destruction by DNase I on characteristics of forming biofilms. DNA Cell Biol 2010; 29: 399-405.
8. Pierce CG, Uppuluri P, Tristan AR et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc 2008; 3: 1494-500.
9. Martins M, Henriques M, Azeredo J, Rocha SM, Coimbra MA, Oliveira R. Candida species extracellular alcohols: production and effect in sessile cells. J Basic Microbiol 2010; 20: S89-97.
10. Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001; 45: 2475-9.
11. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001; 183: 5385-94.
12. Al-Dhaheri RS, Douglas LJ. Absence of amphotericin B-tolerant persister cells in biofilms of some Candida species. Antimicrob Agents Chemother 2008; 18: 1884-7.
13. Bachmann SP, Vandewalle K, Ramage G et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 2002; 46: 3591-6.
14. Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002; 46: 1773-80.
15. Ramage G, Vandewalle K, Bachmann SP, Wickes BL, Lopez-Ribot JL. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 2002; 46: 3634-6.
16. LaFleur MD, Kumamoto CA, Lewis K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 2006; 50: 3839-46.
17. Ferreira JA, Carr JH, Starling CE, de Resende MA, Donlan RM. Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates. Antimicrob Agents Chemother 2009; 53: 4377-84.
18. Tobudic S, Kratzer C, Lassnigg A, Graninger W, Presterl E. In vitro activity of antifungal combinations against Candida albicans biofilms. J Antimicrob Chemother 2010; 65: 271-4.
19. Wiederhold NP. Attenuation of echinocandin activity at elevated concentrations: a review of the paradoxical effect. Curr Opin Infect Dis 2007; 20: 574-8.
20. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010; 35: 322-32.
21. Tetz GV, Artemenko NK, Tetz VV. Effect of DNase and antibiotics on biofilm characteristics. Antimicrob Agents Chemother 2009; 53: 1204-9.
22. Mulcahy H, Charron-Mazenod L, Lewenza S. Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog 2008; 4: e1000213.
23. Kaplan JB. Therapeutic potential of biofilm-dispersing enzymes. Int J Artif Organs 2009; 32: 545-54.
24. Allesen-Holm M, Barken KB, Yang L. et al. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol 2006; 59: 1114-28.
25. Vilain S, Pretorius JM, Theron J, Brozel VS. DNA as an adhesin: Bacillus cereus requires extracellular DNA to form biofilm. Appl Environ Microbiol 2009; 75: 2861-8.
26. Al-Fattani MA, Douglas LJ. Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Chemother 2004; 48: 3291-7.
27. Nett JE, Sanchez H, Cain MT, Andes DR. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J Infect Dis 2010; 202: 171-5.